Radius Health Inc. [NASDAQ: RDUS] slipped around -0.04 points on Tuesday, while shares priced at $12.15 at the close of the session, down -0.37%. The company report on July 27, 2020 that Radius Health to Announce Second Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Monday, August 10, 2020.
Radius Health (Nasdaq: RDUS) announced today that it will release its second quarter financial results on Monday, August 10, 2020. The Company will host a conference call and live audio webcast at 8:30 a.m. ET that day to discuss the results and provide a company update.
Conference Call Information: Date: Monday, August 10, 2020 Time: 8:30 a.m. ET Domestic Dial-In Number: (866) 323-7965 International Dial-In Number: (346) 406-0961 Conference ID: 6334188.
Radius Health Inc. stock is now -39.73% down from its year-to-date (YTD) trading value. RDUS Stock saw the intraday high of $12.33 and lowest of $11.80 per share. The company’s 52-week high price is 29.97, which means current price is +17.73% above from all time high which was touched on 03/02/20.
Compared to the average trading volume of 597.53K shares, RDUS reached a trading volume of 1232974 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Radius Health Inc. [RDUS]?
SVB Leerink have made an estimate for Radius Health Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on July 08, 2020. The new note on the price target was released on May 13, 2020, representing the official price target for Radius Health Inc. stock. Previously, the target price had yet another raise to $20, while Stifel analysts kept a Hold rating on RDUS stock. On August 29, 2019, analysts increased their price target for RDUS shares from 24 to 40.
The Average True Range (ATR) for Radius Health Inc. is set at 0.85, with the Price to Sales ratio for RDUS stock in the period of the last 12 months amounting to 3.09.
How has RDUS stock performed recently?
Radius Health Inc. [RDUS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.65. With this latest performance, RDUS shares dropped by -14.26% in over the last four-week period, additionally sinking by -37.44% over the last 6 months – not to mention a drop of -38.23% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RDUS stock in for the last two-week period is set at 40.22, with the RSI for the last a single of trading hit 36.20, and the three-weeks RSI is set at 42.64 for Radius Health Inc. [RDUS]. The present Moving Average for the last 50 days of trading for this stock 13.23, while it was recorded at 12.57 for the last single week of trading, and 17.58 for the last 200 days.
Radius Health Inc. [RDUS]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Radius Health Inc. [RDUS] shares currently have an operating margin of -64.75 and a Gross Margin at +89.85. Radius Health Inc.’s Net Margin is presently recorded at -76.73.
Return on Total Capital for RDUS is now -56.04, given the latest momentum, and Return on Invested Capital for the company is -66.78. Return on Equity for this stock declined to -1,449.28, with Return on Assets sitting at -52.55. Additionally, RDUS Total Debt to Total Capital is recorded at 126.41, with Total Debt to Total Assets ending up at 92.34.
Reflecting on the efficiency of the workforce at the company, Radius Health Inc. [RDUS] managed to generate an average of -$347,240 per employee. Receivables Turnover for the company is 8.66 with a Total Asset Turnover recorded at a value of 0.68.Radius Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.00 and a Current Ratio set at 3.10.
Earnings analysis for Radius Health Inc. [RDUS]
With the latest financial reports released by the company, Radius Health Inc. posted -0.77/share EPS, while the average EPS was predicted by analysts to be reported at -0.87/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 11.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RDUS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Radius Health Inc. go to 29.60%.
Insider trade positions for Radius Health Inc. [RDUS]
There are presently around $598 million, in the hands of institutional investors. The top three institutional holders of RDUS stocks are: BELLEVUE GROUP AG with ownership of 6,983,385, which is approximately 0.591% of the company’s market cap and around 0.50% of the total institutional ownership; PRICE T ROWE ASSOCIATES INC /MD/, holding 5,505,633 shares of the stock with an approximate value of $66.89 million in RDUS stocks shares; and WELLINGTON MANAGEMENT GROUP LLP, currently with $58.47 million in RDUS stock with ownership of nearly 22.343% of the company’s market capitalization.
Positions in Radius Health Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 64 institutional holders increased their position in Radius Health Inc. [NASDAQ:RDUS] by around 3,869,090 shares. Additionally, 79 investors decreased positions by around 4,156,936 shares, while 20 investors held positions by with 41,175,269 shares. The mentioned changes placed institutional holdings at 49,201,295 shares, according to the latest SEC report filing. RDUS stock had 12 new institutional investments in for a total of 767,833 shares, while 29 institutional investors sold positions of 1,209,923 shares during the same period.